Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- (R)-etodolac
- DrugBank Accession Number
- DB18776
- Background
Not Available
- Type
- Small Molecule
- Groups
- Investigational
- Structure
Structure for (R)-etodolac (DB18776)
- Weight
- Average: 287.359
Monoisotopic: 287.15214354 - Chemical Formula
- C17H21NO3
- Synonyms
- (-)-(r)-etodolac
- (-)-etodolac
- (1r)-1,8-diethyl-1,3,4,9-tetrahydropyrano(3,4-b)indole-1-acetic acid
- Etodolac, (-)-
- Etodolac, (R)-
- Pyrano(3,4-b)indole-1-acetic acid, 1,8-diethyl-1,3,4,9-tetrahydro-, (1r)-
- Pyrano(3,4-b)indole-1-acetic acid, 1,8-diethyl-1,3,4,9-tetrahydro-, (r)-
- R-etodolac
- External IDs
- KS-1056
- RAK-593
- SDX-101
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- Y1RAH31T6K
- CAS number
- 87226-41-3
- InChI Key
- NNYBQONXHNTVIJ-QGZVFWFLSA-N
- InChI
- InChI=1S/C17H21NO3/c1-3-11-6-5-7-12-13-8-9-21-17(4-2,10-14(19)20)16(13)18-15(11)12/h5-7,18H,3-4,8-10H2,1-2H3,(H,19,20)/t17-/m0/s1
- IUPAC Name
- SMILES
- CCC1=C2NC3=C(CCO[C@]3(CC)CC(O)=O)C2=CC=C1
References
- General References
- Not Available
- External Links
- ChemSpider
- 580901
- ChEBI
- 60370
- ChEMBL
- CHEMBL1716091
- ZINC
- ZINC000000003642
- PDBe Ligand
- 8QS
- PDB Entries
- 5v0v
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data2 Terminated Treatment Chronic Lymphocytic Leukemia 1 somestatus stop reason just information to hide 2 Terminated Treatment Multiple Myeloma (MM) 1 somestatus stop reason just information to hide
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at June 19, 2024 21:38 / Updated at June 21, 2024 20:33